Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (311-320 of 358) with videos related to

Pageof 36
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical TrialAlessandro Lazzaro, Daniela Vai, Ambra Barco, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2012
Mortality in patients with early- or late-onset candidaemiaFrancesco Giuseppe De Rosa, Enrico Maria Trecarichi, Chiara Montrucchio, et al.
Microorganisms|November 27, 2021
Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective StudyNicole Pagani, Silvia Corcione, Tommaso Lupia, et al.
Diagnostics (Basel, Switzerland)|March 3, 2021
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control StudyStefano Cosma, Andrea Roberto Carosso, Fulvio Borella, et al.
The Pharmacogenomics Journal|October 20, 2022
Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-studyRohan Gurjar, Laura Dickinson, Daniel Carr, et al.
International Journal of STD & AIDS|January 8, 2025
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohortAndrea Antinori, Giulia Marchetti, Vincenzo Esposito, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
Plos One|October 18, 2019
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" CohortEmanuele Focà, Paola Magro, Giovanni Guaraldi, et al.
Therapeutic Drug Monitoring|March 13, 2012
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatmentAntonio DʼAvolio, Alessia Ciancio, Marco Siccardi, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatmentStefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.
Pageof 36

Showing results (311-320 of 358) with videos related to

Sort By:
Pageof 36
Journal of Acquired Immune Deficiency Syndromes (1999)|September 9, 2024
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical TrialAlessandro Lazzaro, Daniela Vai, Ambra Barco, et al.
The Journal of Antimicrobial Chemotherapy|December 14, 2012
Mortality in patients with early- or late-onset candidaemiaFrancesco Giuseppe De Rosa, Enrico Maria Trecarichi, Chiara Montrucchio, et al.
Microorganisms|November 27, 2021
Carbapenemase-Producing <i>Klebsiella pneumoniae</i> Colonization and Infection in Solid Organ Transplant Recipients: A Single-Center, Retrospective StudyNicole Pagani, Silvia Corcione, Tommaso Lupia, et al.
Diagnostics (Basel, Switzerland)|March 3, 2021
Prenatal Biochemical and Ultrasound Markers in COVID-19 Pregnant Patients: A Prospective Case-Control StudyStefano Cosma, Andrea Roberto Carosso, Fulvio Borella, et al.
The Pharmacogenomics Journal|October 20, 2022
Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-studyRohan Gurjar, Laura Dickinson, Daniel Carr, et al.
International Journal of STD & AIDS|January 8, 2025
Effectiveness, safety, and patient-reported outcomes of bictegravir/emtricitabine/tenofovir alafenamide in routine clinical care in Italy: 12-Month results from the BICSTaR cohortAndrea Antinori, Giulia Marchetti, Vincenzo Esposito, et al.
AIDS Patient Care and Stds|December 22, 2007
Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe StudyMaria Mercedes Santoro, Ada Bertoli, Patrizia Lorenzini, et al.
Plos One|October 18, 2019
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" CohortEmanuele Focà, Paola Magro, Giovanni Guaraldi, et al.
Therapeutic Drug Monitoring|March 13, 2012
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatmentAntonio DʼAvolio, Alessia Ciancio, Marco Siccardi, et al.
The Journal of Antimicrobial Chemotherapy|August 8, 2006
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatmentStefano Aquaro, Roberta D'Arrigo, Valentina Svicher, et al.
Pageof 36